Charles River Laboratories International, Inc. CRL
Set alert
338.54 USD -20.87 -5.81%
At close
335.00 -3.54 -1.05%
Pre-market · Nov 3, 5:10 AM ET
337.38 Day range 369.61
146.20 52-week range 379.63
- YTD
- +69.71%
- 1 year
- +89.28%
- Open
- 368.42
- Prev close
- 359.41
- Mkt cap
- 16.16B
- Vol
- 1.62M
- Avg vol
- 1.03M
- EPS
- -4.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 337.38
- High
- 369.61
- Forward P/E
- 26.55
- Beta
- 1.34
- Short ratio
- 2.77
- Inst. own
- 122.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 301.91
- 200-d avg
- 221.78
- 1y target
- 318.87
MAX chart
Events in this range
- Aug 6, 2025Earnings: 3.12; estimate 2.5; surprise 24.8%
- Nov 5, 2025Earnings: 2.43; estimate 2.32; surprise 4.74%
- May 7, 2026Earnings: 2.06; estimate 1.96; surprise 5.1%
- Aug 5, 2026Earnings: 3.02; estimate 2.74; surprise 10.22%
- Nov 4, 2026Earnings: —; estimate 2.97; surprise —%
Signals (107)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | May 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
Newest 20 of 107.
Analyst view
Consensus: buy
Buy
Price target (mean) 318.87 -5.8% downside
Now 338.54
- Target (low)
- 145.00
- Target (mean)
- 318.87
- Target (high)
- 390.00
Ratings (0m) 17 14 buy · 2 hold · 1 sell
- Strong buy3
- Buy11
- Hold2
- Sell1
- Strong sell0
Recommendation trend
- This month 17
- 1 month ago 18
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.97 | 2.93 – 3.09 | 2.43 | +22.3% | 960.36M | -4.4% | 13 |
| Next quarter | 3.33 | 3.00 – 3.44 | 2.39 | +39.3% | 956.35M | -3.8% | 13 |
| Current year | 11.38 | 11.02 – 11.49 | 10.28 | +10.7% | 3.92B | -2.5% | 17 |
| Next year | 12.75 | 11.90 – 13.68 | 11.38 | +12.0% | 4.02B | +2.5% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 28, 2026 | Jefferies | Maintained | Buy | Buy |
| Sep 25, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Sep 25, 2026 | TD Cowen | Maintained | Buy | Buy |
| Sep 25, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Sep 25, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 25, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Sep 25, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 11, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 10, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Jul 20, 2026 | CLSA | Downgrade | Outperform | Hold |
| Jul 13, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 17, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| May 29, 2026 | CLSA | Upgrade | Hold | Outperform |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 8, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 20, 2026 | TD Cowen | Maintained | Buy | Buy |
| Feb 20, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Feb 19, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 19, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jan 16, 2026 | Citigroup | Maintained | Buy | Buy |